Page 7 - Neurosciences Program Phd News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Neurosciences program phd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Neurosciences Program Phd Today - Breaking & Trending Today

Minerva Neurosciences, Inc: Minerva Neurosciences Reports Fiscal Year 2022 Fourth Quarter And Year End Financial Results And Business Updates

Company to Host Conference Call Today at 8:30 a.m. ETBURLINGTON, Mass., March 08, 2023(Nasdaq: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central ....

Dennis Riedl , Helen Shik , Remy Luthringer , Frederick Ahlholm , Minerva Neurosciences , Shik Communications , Company To Host Conference Call , Minerva Neurosciences Inc , Host Conference Call Today , Executive Chairman , Chief Executive Officer , Year End Financial , Federal Food Drug , Cosmetic Act , Call Information , Private Securities Litigation Reform Act , Term Liabilities , Months Ended December ,

Cognetivity Neurosciences Ltd.: Cognetivity Neurosciences Announces Commercial Deployment at Leading Psychiatry and Neurology Centre in UAE

Latest Agreement Signals Continued, Rapid Commercial Growth in Middle East Region
Vancouver, British Columbia (Newsfile Corp. - February 23, 2023) - Cognetivity Neurosciences Ltd. (CSE: CGN) (OTCQB: ....

Al Qahirah , United Arab Emirates , United States , United Kingdom , British Columbia , Dennis Riedl , Abu Dhabi , George Tadros , Sina Habibi , Cognetivity Cogn , United Kingdom National Health Service , American Center , Company Or Cognetivity , British Columbia Newsfile Corp , Global Health Delivery , Aston University , Cognetivity Neurosciences Ltd , Cairo Medical School , Harvard Medical School Center , Canadian Securities Exchange , Chester University , Latest Agreement Signals Continued , Rapid Commercial Growth , Middle East , North America , National Health Service ,

Cognetivity Neurosciences Ltd.: Cognetivity Announces Further Scientific Evidence of its AI-Powered CognICA Platform's Ability to Detect and Monitor Cognitive Impairment in Patients With Multiple Sclerosis

Peer-reviewed article demonstrates effectiveness of company's technology in major disease area with global application for the detection and monitoring of disease
Vancouver, British Columbia (Newsfile ....

United States , United Kingdom , British Columbia , Dennis Riedl , Sina Habibi , Cognetivity Cogn , Cognetivity Neurosciences Ltd , Company Or Cognetivity , British Columbia Newsfile Corp , Canadian Securities Exchange , Integrated Cognitive Assessment , Multiple Sclerosis , Artificial Intelligence , Middle East , Executive Officer ,

"Improving treatment outcomes for borderline personality disorder: What" by Ely M. Marceau, Anthony C. Ruocco et al.

Purpose of reviewBorderline personality disorder (BPD) is a severe and common psychiatric disorder and though evidence-based psychotherapies are effective, rates of treatment nonresponse are as high as 50%. Treatment studies may benefit from interdisciplinary approaches from neuroscience and genetics research that could generate novel insights into treatment mechanisms and tailoring interventions to the individual.Recent findingsWe provide a timely update to the small but growing body of literature investigating neurobiological and epigenetic changes and using biomarkers to predict outcomes from evidence-based psychotherapies for BPD. Using a rapid review methodology, we identified eight new studies, updating our earlier 2018 systematic review. Across all studies, neuroimaging (n = 18) and genetics studies (n = 4) provide data from 735 participants diagnosed with BPD (mean sample size across studies = 33.4, range 2-115).SummaryWe report further evidence for psychotherapy-related altera ....

Borderline Personality Disorder , Treatment Outcome ,

Cognetivity Neurosciences Ltd.: Cognetivity Neurosciences Releases Latest Version of AI-powered Brain Health Assessment Platform

With global interest in AI at an all-time high, latest update to Cognetivity's flagship medical device affirms company's sustained commitment to being at the forefront of AI in healthcare
Vancouver, British ....

United States , United Kingdom , British Columbia , Dennis Riedl , Sina Habibi , United Kingdom National Health Service , Cognetivity Neurosciences Ltd , Company Or Cognetivity , British Columbia Newsfile Corp , Canadian Securities Exchange , North America , Southeast Asia , Middle East , National Health Service , Artificial Intelligence , Executive Officer ,